GlassScriptPhysician profile
Carrie Snyder
NPI 1043620917
$161.51
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Oncology (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.02 · 2022: $78.49.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $38.20 | 2022 | |
| Incyte Corporation | $15.64 | 2021 | |
| Kyowa Kirin, INC. | $14.94 | 2021 | |
| G1 Therapeutics, INC. | $14.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.90 | 2021 | |
| Amgen INC. | $13.61 | 2022 | |
| Blueprint Medicines Corporation | $13.47 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.62 | 2022 | |
| Morphosys, US INC. | $12.60 | 2021 | |
| Karyopharm Therapeutics INC. | $12.47 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.